Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) model resistant to neoadjuvant chemotherapy (NAC)

These results indicate that FGS can significantly reduce local recurrence compared to BLS in pancreatic cancer resistant to NAC.